These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 15007713

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Renal impairment associated with indomethacin treatment for patent ductus arteriosus in extremely preterm neonates--is postnatal age at start of treatment important?
    Srinivasjois RM, Nathan EA, Doherty DA, Patole SK.
    J Matern Fetal Neonatal Med; 2006 Dec; 19(12):793-9. PubMed ID: 17190690
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neonatal acute kidney injury during indomethacin therapy: does it predict ductal closure?
    Dias Maia P, Rodrigues KK, Gien J, Turner MJ.
    J Nephrol; 2023 Jul; 36(6):1591-1597. PubMed ID: 37097555
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Furosemide does not prevent indomethacin-induced renal side effects in preterm infants.
    Romagnoli C, Zecca E, Papacci P, De Carolis MP, Giannini R, Gallini F, Tortorolo G.
    Clin Pharmacol Ther; 1997 Aug; 62(2):181-6. PubMed ID: 9284854
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K, Ohno T, Nishida H.
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [Abstract] [Full Text] [Related]

  • 10. Comparison of renal effects of ibuprofen versus indomethacin during treatment of patent ductus arteriosus in contiguous historical cohorts.
    Kushnir A, Pinheiro JM.
    BMC Clin Pharmacol; 2011 Jun 30; 11():8. PubMed ID: 21718490
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Potential Unintended Consequences of a Conservative Management Strategy for Patent Ductus Arteriosus.
    Elhoff JJ, Ebeling M, Hulsey TC, Atz AM.
    Congenit Heart Dis; 2016 Jun 30; 11(1):52-7. PubMed ID: 26193967
    [Abstract] [Full Text] [Related]

  • 13. Treatment of patent ductus arteriosus with low-dose indomethacin in very low birth weight neonates with impairment of renal function: report of three cases.
    Kuo CY.
    J Perinat Med; 1996 Jun 30; 24(6):657-60. PubMed ID: 9120749
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of two neonatal indomethacin protocols: efficacy and outcome for patent ductus arteriosus closure.
    Rosito G, Sum K, Chorne N.
    J Clin Pharm Ther; 2010 Oct 30; 35(5):589-92. PubMed ID: 20831682
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Indomethacin treatment decreases renal blood flow velocity in human neonates.
    Kang NS, Yoo KH, Cheon H, Choi BM, Hong YS, Lee JW, Kim SK.
    Biol Neonate; 1999 Nov 30; 76(5):261-5. PubMed ID: 10516392
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S, Limrungsikul A, Khowsathit P.
    J Med Assoc Thai; 2002 Nov 30; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [Abstract] [Full Text] [Related]

  • 20. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
    Fujii AM, Brown E, Mirochnick M, O'Brien S, Kaufman G.
    J Perinatol; 2002 Nov 30; 22(7):535-40. PubMed ID: 12368968
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.